Placebo News and Research

RSS

Weekly doses of steroids help hasten recovery in muscle injuries

Weekly doses of glucocorticoid steroids, such as prednisone, help speed recovery in muscle injuries, reports a new Northwestern Medicine study. The weekly steroids also repaired muscles damaged by muscular dystrophy.

17 May 2017

Untargeted vitamin D supplementation provides little clinical benefit to older adults, study finds

An international study of older adults has found that mass, untargeted provision of vitamin D supplements provides little clinical benefit to many when it comes to the common bone disease, osteoporosis. Instead, the study recommends targeting vitamin D supplements at individuals whose levels of this vitamin are markedly reduced.

16 May 2017

Year-round flu vaccinations for pregnant mothers benefit babies in subtropical regions

Vaccinating pregnant mothers year-round against flu in the resource-challenged region of subtropical Nepal reduced infant flu virus infection rates by an average of 30 percent, increased birth weights by 15 percent and resulted in babies having less influenza, according to a study published in The Lancet Infectious Diseases.

16 May 2017

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.

12 May 2017

Suppression of thyroid hormone receptor protects cone cells in mouse models of retinal diseases

New research published online in The FASEB Journal suggests that the suppression of thyroid hormone receptor activity locally in the retina protects cone photoreceptor cells in mouse models of human retinal degenerative diseases

11 May 2017

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

According to a meta-analysis of three randomized controlled trials published in Open Forum Infectious Diseases, zinc acetate lozenges may increase the rate of recovery from the common cold three fold. On the fifth day, 70% of the zinc lozenge patients had recovered compared with 27% of the placebo patients.

11 May 2017

Breast cancer drug offers protection against obesity-related metabolic disorders

Tamoxifen, a selective estrogen receptor modulator, is the gold standard for endocrine treatment of estrogen-receptor positive breast cancer.

11 May 2017

Study explores use of beetroot juice as targeted treatment option for people with heart disease

A new study finds that dietary nitrate- a compound that dilates blood vessels to decrease blood pressure- may reduce overstimulation of the sympathetic nervous system that occurs with heart disease.

11 May 2017

New clinical study aims to prevent onset of epilepsy in children with tuberous sclerosis

A clinical trial of a drug that researchers hope can prevent or delay the onset of epilepsy in children with tuberous sclerosis has begun at McGovern Medical School at The University of Texas Health Science Center at Houston.

8 May 2017

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

Researchers have found that taking an enzyme tablet while consuming foods containing gluten prevents a significant amount of it from entering the small intestine.

8 May 2017

FDA approves new treatment for people with ALS

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis, commonly referred to as Lou Gehrig's disease.

5 May 2017

Study shows how feelings of clinician-patient similarity and trust can help reduce pain

Getting a shot at your doctor's office can be a stressful experience. But what if you knew your doctor was from your hometown, liked the same food as you, or shared your religious beliefs? Now that you feel more culturally connected to your doctor, will the shot hurt less?

5 May 2017

Breakthrough therapy reduces symptoms of Graves' eye disease in clinical trials

The disease is characterized by inflammation and a buildup of tissue around the eyes that cause them to bulge painfully from their sockets.

4 May 2017

Study finds no increase in muscle-related symptoms when patients are unaware of taking statin therapy

When patients were unaware they were taking statins there was no reported increase in muscle-related symptoms. But, when patients knew they were taking a statin, they were more likely to report symptoms, a finding consistent with the nocebo effect.

4 May 2017

Steroids offer no additional relief to emergency patients suffering from hives

Despite standard use for the itching associated with urticaria (commonly known as hives), prednisone (a steroid) offered no additional relief to emergency patients suffering from hives than a placebo did, according to a randomized, placebo-controlled, double-blind, parallel-group study published online yesterday in Annals of Emergency Medicine.

4 May 2017

Study shows how probiotic improves integrity of the GI epithelial cell wall in HIV patients

A newly released study published in the Journal of Immunity, Inflammation and Disease and conducted by the Sapienza University of Rome, Italy, found a multi-strain, high concentration, probiotic formulation that helped reconstitute the physical and immunological integrity of the gastrointestinal lining in HIV-1-positive patients on antiretroviral therapy.

3 May 2017

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.

3 May 2017

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Shire plc and Parion Sciences, Inc. have announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead development of P-321, an investigational epithelial sodium channel (ENaC) inhibitor for the potential treatment of dry eye disease in adults, with the opportunity for Parion to co-fund.

3 May 2017

Parent-involved therapies found to be effective in treating children with disruptive behavior disorders

Therapy that involves the parents in the treatment of children with disruptive behavior disorders shows the best results compared to more than 20 other therapeutic approaches, according to a new study published today in the Journal of Clinical Child and Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.

2 May 2017

Low-cost drug for severe bleeding could save lives of mothers after childbirth

An inexpensive and widely available drug could save the lives of one in three mothers who would otherwise bleed to death after childbirth, according to a major study published in The Lancet. The global trial of 20,000 women found that death due to bleeding was reduced by 31% if the treatment was given within three hours.

29 Apr 2017

Placebo News and Research

Weekly doses of steroids help hasten recovery in muscle injuries

Untargeted vitamin D supplementation provides little clinical benefit to older adults, study finds

Year-round flu vaccinations for pregnant mothers benefit babies in subtropical regions

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

Suppression of thyroid hormone receptor protects cone cells in mouse models of retinal diseases

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

Breast cancer drug offers protection against obesity-related metabolic disorders

Study explores use of beetroot juice as targeted treatment option for people with heart disease

New clinical study aims to prevent onset of epilepsy in children with tuberous sclerosis

Enzyme supplement can potentially reduce uncomfortable symptoms in gluten-sensitive patients

FDA approves new treatment for people with ALS

Study shows how feelings of clinician-patient similarity and trust can help reduce pain

Breakthrough therapy reduces symptoms of Graves' eye disease in clinical trials

Study finds no increase in muscle-related symptoms when patients are unaware of taking statin therapy

Steroids offer no additional relief to emergency patients suffering from hives

Study shows how probiotic improves integrity of the GI epithelial cell wall in HIV patients

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Parent-involved therapies found to be effective in treating children with disruptive behavior disorders

Low-cost drug for severe bleeding could save lives of mothers after childbirth

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News